Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood testing
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Blood Testing Articles & Analysis

191 news found

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

The previous guidelines for asthma management from NICE recommended FeNO testing alongside other objective tests, such as spirometry and peak flow. ...

ByBedfont Scientific Limited


Medical Equipment Pump Solutions

Medical Equipment Pump Solutions

Medical Equipment Pump Solutions Industry Overview IVD, which stands for in vitro diagnostics, refers to products that conduct testing on samples taken from the human body (such as blood, body fluids, and tissues) outside of the body in order to obtain clinical diagnostic information. The IVD industry is subdivided into various sectors including ...

ByTops Industry & Technology Co.,Ltd.


FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)

FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)

The SFLO series is applicable to a wide range of laboratory applications, including blood, tumour, immunophenotyping, pharmacology testing, cell biology analysis, bioengineering, pharmacology, medical research, haematology, analysis of intracellular antigenic substances, biosafety testing, blood and cell analysis, and tumour cell ...

ByFocused Photonics Inc. (FPI)


Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation


Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients

Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients

In both study arms, patients had BVA testing within a day of admission and one day prior to discharge, along with physician assessment for congestion. Study results showed little to no correlation between physician assessment of congestion on admission compared to BVA results, and those that received BVA-guided treatment had a strong trend toward lower total hospital length of ...

ByHeart Failure Society of America, Inc. (HFSA)


New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation


Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

” About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide ...

ByDaxor Corporation


Daxor Corporation Appoints Linda Cooper, Vice President Project Management

Daxor Corporation Appoints Linda Cooper, Vice President Project Management

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation


How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

Researchers can now assess metabolic fluxes rather than relying on the static snapshot of a traditional blood test. As a result, a deeper understanding of cellular metabolic differences can be realized and aid in discovering potential therapeutic targets. ...

ByLifespin GmbH


Why Knowledge Is Power In The Treatment Of Obesity

Why Knowledge Is Power In The Treatment Of Obesity

Dr. Ali Tinazli is the CEO of lifespin.health and has 15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP). Obesity rates continue to climb alongside a $254.9 billion global weight loss products and services market. Supplements, smartphone weight loss apps, diet plans and exercise programs are widely available to consumers, yet the World Obesity Federation projects that 1 ...

ByLifespin GmbH


Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation


LifeScan’s Response to the Invasion of Ukraine

LifeScan’s Response to the Invasion of Ukraine

As part of our longstanding commitment to supporting numerous relief efforts around the world, LifeScan is working with the non-profit humanitarian organization, Direct Relief, to respond to the urgent need to supply much-needed blood glucose testing supplies to the many Ukrainians now without access to critical health products. ...

ByLifeScan


Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Data from the study demonstrated a lack of correlation between pressure measures and actual blood volume, highlighting the need for direct and 98% accurate volume measurement that the BVA-100 blood test provides. ...

ByDaxor Corporation


Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option

Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option

About Daxor: Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, ...

ByDaxor Corporation


Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering

About Daxor: Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, ...

ByDaxor Corporation


Daxor Corporation Announces Launch of Proposed Underwritten Public Offering

Daxor Corporation Announces Launch of Proposed Underwritten Public Offering

About Daxor Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, ...

ByDaxor Corporation


New and Encouraging Global Diabetes Market Research Shows People with Diabetes are More Motivated to Manage their Condition than Healthcare Providers May Realize

New and Encouraging Global Diabetes Market Research Shows People with Diabetes are More Motivated to Manage their Condition than Healthcare Providers May Realize

“Knowing people are motivated is a powerful insight that could lead a healthcare provider to recommend patients new and possibly more holistic diabetes management plans integrating diet, exercise, blood glucose testing, and taking advantage of apps to track and share health ...

ByLifeScan


Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation


Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Patients presenting to the hospital or outpatient clinic with clinical worsening HF underwent blood volume analysis measured with Daxor’s BVA-100 diagnostic blood test, right heart catheterization, provocative testing including blood pressure measurement, leg raises, breathing techniques, and patient ...

ByDaxor Corporation


Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022

Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022

About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, ...

ByDaxor Corporation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT